HFCL Share Price Rise After RVNL Order: ₹2,666 Crore Win and What Indian Retail Investors Should Do

Key Takeaways

• HFCL jumped 4% on the ₹2,666 crore RVNL order.
• The move is described by NDTV Profit as a near-term catalyst.
• The article does not detail product scope or revenue impact.
• Investors should assess the one-off nature of this catalyst and watch for further disclosures.

In a market where government contracts can move sentiment, HFCL lit the fuse with a 4% jump after RVNL's ₹2,666 crore order win, per NDTV Profit. The move is a reminder that near-term catalysts can be powerful, even when long-term fundamentals stay unchanged. For retail investors across India, the question is how to interpret this signal and what it means for risk and opportunity today.

Quick take for busy investors:

why HFCL share price rose after RVNL order: the core trigger for Indian retail investors

The NDTV Profit article notes that HFCL's shares rose around 4% following the order win from Rail Vikas Nigam Limited (RVNL). The size of the contract at ₹2,666 crore is material for a mid-cap name like HFCL and can lift sentiment in the near term. However, the article does not provide details on the product lines, margins, or the exact revenue recognition timeline. Hence, investors should view this as a near-term catalyst, not a confirmation of sustained earnings growth.

For full coverage, see the NDTV Profit article here: NDTV Profit coverage.

how big is the RVNL order and what does it cover for HFCL's near-term outlook

The article confirms the order value at ₹2,666 crore. It does not elaborate on the specific telecom equipment or segments involved or the execution timeline. Because of that, it's challenging to gauge the order's immediate impact on HFCL's quarterly revenue or margins. Consequently, it should be interpreted as a sizable one-off win that might boost order inflows in the short term but requires more disclosures for long-term visibility.

what does this mean for HFCL's revenue outlook and risk: is one order enough to justify a rally?

Rally driven by a single government order can create a price spike, but it does not automatically translate into lasting fundamentals. The NDTV Profit report focuses on the stock price reaction rather than a detailed revenue backlog or margin expansion. For investors, the key questions are whether HFCL can convert this order into sustained revenue and how it impacts profitability. The article does not answer these questions, so caution and further confirmation are prudent.

how retail investors can position HFCL in a diversified Indian stock portfolio after the RVNL win

Take the rally as a potential near-term catalyst and avoid chasing the momentum without checking fundamentals. A prudent approach is to monitor follow-up disclosures, watch for progress on the order's execution, and compare HFCL's valuations and earnings trajectory against peers in the telecom equipment space. If you want deeper, institution-grade research on HFCL and other stocks, Swastika's Sarthi AI stock assistant can deliver insights on trend, momentum, and risk, helping you make informed decisions.

what to watch next after HFCL's RVNL order: signals to confirm the trend

Investors should monitor the follow-up news: other orders, the backlog, and the company's quarterly performance. This article does not include those details; look for future disclosures from HFCL and RVNL for better clarity on sustainability.

FAQ

What triggered HFCL's rally after the RVNL order?

HFCL's shares rose about 4% after Rail Vikas Nigam Limited announced a ₹2,666 crore order, as reported by NDTV Profit.

How large is the RVNL order HFCL won?

The order value is ₹2,666 crore.

Does the article provide product details or a timeline for the RVNL order?

No. The NDTV Profit piece states the order value but does not specify product lines, segments, or the execution timeline.

Should investors expect HFCL's growth to be sustained on this single order?

The article describes a near-term price movement due to one order and does not provide long-term guidance or confirmation of sustained revenue growth.

Where can investors find more analysis about HFCL and similar opportunities?

This blog summarizes the NDTV Profit report; for deeper research, retail investors can consider Swastika's research tools, such as Sarthi AI, for broader stock analysis.

Conclusion

In the near term, HFCL's 4% rally on a ₹2,666 crore RVNL order highlights how government contracts can act as catalysts in India's infrastructure and telecom equipment space. It is a reminder that a single win can create momentum, but not necessarily translate into durable earnings growth. Retail investors across India should treat such moves as a signal to watch for transparency in execution, order backlog development, and quarterly results before adjusting long-term bets.

Next-step mental model: separate catalysts from fundamentals. Use this order as a trigger to gather more information, monitor subsequent disclosures, and only reweight HFCL in your portfolio after confirming sustained revenue visibility and margin stability.

Open your trading and demat account here

Key Takeaways

• The US Federal Reserve's hawkish tone triggered a sell-off in Indian IT stocks, with Infosys, TCS, and Wipro falling up to 3%.
• Near-term moves hinge on US rate expectations, dollar moves, and global tech demand signals.
• Valuations may offer entry points if macro cues stabilize and IT demand remains intact.
• Use Swastika's Sarthi AI stock assistant for deeper research and risk-aware stock selection.

The hawkish tone from the US Federal Reserve has rattled global markets, and Indian IT stocks were not spared. On the trading day, Infosys, TCS, and Wipro fell up to 3%, a reminder that macro cues can quickly translate into sector-specific moves for retail investors in India. This piece breaks down what the move means for you and how to navigate the likely path ahead.

What did the Fed hawkish tone mean for Infosys, TCS, and Wipro in Indian markets?

According to the news coverage, the hawkish stance suggests rates could stay higher for longer. When US policy shifts, Indian IT names–where a sizeable share of revenue comes from North America–tend to react through valuation re-pricings and volatility. The immediate consequence observed in the ET report was a drop in Infosys, TCS, and Wipro of up to 3%, underscoring how interconnected global macro cues are with Indian equity moves.

Near-term risks for Indian IT stocks after the Fed hawkish tone

The day’s movement highlights several short-term risk factors: persistent US rate expectations, potential dollar strength, and the risk-off mood in global tech shares. If the US path remains hawkish, Indian IT valuations could stay pressured in the near term, even if the longer-term demand narrative for technology services stays positive. For retail investors, recognizing this volatility and avoiding aggressive concentration in a few names can help manage risk.

How retail investors can navigate volatility after the Fed stance

Practical steps include sticking to a disciplined risk framework, diversifying across multiple IT names, and prioritizing companies with robust order books and healthy cash flow. Consider staggered entry on price dips rather than committing capital all at once, and lean toward quality over momentum. For investors seeking deeper, stock-specific insights, Swastika’s Sarthi AI stock assistant offers institutional-grade research for retail users: Sarthi AI stock assistant.

What to monitor in the coming weeks: Key indicators and data points

• US Federal Reserve policy path and dot plots indicating rate trajectories
• US macro data such as inflation, payrolls, and consumer demand trends
• USD/INR movements and fund flows into Indian IT names
• Q1 earnings guidance and order-book trends from Infosys, TCS, and Wipro
• Overall global tech demand and risk appetite

FAQ

What happened to Infosys, TCS, and Wipro after the Fed hawkish tone?

The Economic Times report notes that Infosys, TCS, and Wipro fell up to 3% on the day as markets priced in a higher-for-longer US rate scenario following the Fed's hawkish tone.

Why do Indian IT stocks react to US Federal Reserve policy?

Indian IT firms derive a large portion of revenue from the US; thus, US rate expectations, currency moves, and global tech demand influence their valuations and investor sentiment, which is reflected in the stock price when the Fed signals tighter policy.

What should Indian retail investors watch next after this move?

Investors should watch the Fed's policy path and US data for clues on rate trajectories, monitor USD/INR movements, and track earnings guidance and order-book trends from Infosys, TCS, and Wipro as highlighted in the article.

Is now a good time to invest in Indian IT stocks?

The article does not issue a buy/sell recommendation; it emphasizes evaluating macro cues, valuations, and company fundamentals. A disciplined approach with diversification and quality stock selection is prudent for retail investors.

How can Swastika's Sarthi AI stock assistant help in this scenario?

Sarthi AI provides institutional-level research on stocks or indices for retail investors, helping to filter for quality IT names, assess risk, and identify suitable entry points amid macro-driven volatility.

Conclusion

The immediate reaction to a hawkish Fed is macro-driven volatility that can unsettle short-term traders, but the long-term case for Indian IT remains supported by digital transformation, large addressable markets, and resilient client relationships. For retail investors, this means recognizing that a pullback can create selective buying opportunities while also demanding a disciplined risk framework.

Open your trading and demat account here

Key Takeaways

• Nykaa's FY30 roadmap targets up to 3x revenue growth.
• The stock jumped 8% to a record high on the roadmap reveal.
• Investors should watch milestones, margins, and execution risk.
• Sarthi AI offers deeper stock insights for Nykaa's plan.

Nykaa’s latest FY30 roadmap promises up to 3x revenue growth by FY30, and the market responded with an 8% jump to a record high. For retail investors across India, this shift invites a deeper look at what such ambitious targets mean in practice, how the company plans to deliver, and what it could cost if expectations outpace execution. In this long-form analysis, we unpack the implications of Nykaa's plan for investors and show you how to think about growth targets in a disciplined way.

This piece draws on the Economic Times report that captured the immediate market reaction to Nykaa's FY30 roadmap. We also highlight how Swastika Investmart's Sarthi AI stock assistant can help you evaluate such a roadmap with data-driven insights. Read the original coverage.

What Nykaa's FY30 roadmap means for revenue growth and key milestones

The core premise of Nykaa's FY30 plan is to target up to 3x revenue by FY30. For retail investors, this implies that Nykaa expects significant expansion across its core segments–online beauty, fashion, and lifestyle products–along with potential monetization improvements on its platform. The roadmap signals confidence in the scalability of the model, including customer acquisition, cross-sell opportunities, and increased order frequency. However, the article does not provide a line-by-line milestone schedule, leaving the exact routes to 3x revenue undefined. In practice, investors should interpret this as a long-term growth thesis rather than a short-term event, with the potential to re-rate the stock if quarterly results consistently support the path to the target.

• Nykaa's FY30 roadmap targets up to 3x revenue growth.
• The stock jumped 8% to a record high after the roadmap reveal.
• Investors should watch for milestones, margins, and execution risk as the plan unfolds.
• Sarthi AI provides deeper stock insights to evaluate Nykaa's plan and potential risk/reward.

Why Nykaa's 8% jump to record high matters for retail investors

The market’s immediate reaction to Nykaa’s roadmap is telling: an 8% uptick signals strong investor appetite for a growth story of this scale. A record-high price suggests that traders are pricing in confidence that Nykaa can translate the roadmap into tangible top-line expansion and, hopefully, improved profitability. But a single day’s move is not a guarantee of future performance, and investors should consider whether the growth narrative aligns with Nykaa’s ability to execute across its platform, supply chains, and customer engagement strategies.

How Nykaa plans to achieve up to 3x revenue growth by FY30: milestones and strategy

Nykaa’s FY30 target suggests a multi-year plan to accelerate revenue through deeper market penetration and monetization. While the Economic Times report highlights the ambitious target itself, it does not lay out a granular year-by-year plan. For investors, the takeaway is to watch for execution milestones such as expansion of high-margin product categories, growth in customer lifetime value, improved operating efficiency, and potential new revenue streams within its e-commerce and beauty ecosystems. The capacity to sustain customer acquisition with improving margins will be critical for turning a top-line target into real earnings power.

Key risks to Nykaa's FY30 revenue targets for retail investors

Ambitious growth targets come with risk. The article frames the 3x goal as a target rather than a guaranteed outcome, so investors should consider execution risk, competitive dynamics in Indian e-commerce, and macroeconomic factors that could impact consumer spending. The absence of a detailed milestone schedule in the coverage means investors should demand clarity on timelines, cost of customer acquisition, and the pace of margin improvements before extrapolating a forever-up ladder.

What should Indian retail investors watch next after Nykaa's FY30 roadmap?

Next steps for investors include monitoring Nykaa’s quarterly performance for signs of traction toward the roadmap, updates on product categories, and any management commentary on capital allocation. Watch how the company manages costs as revenue scales and whether it can sustain gross margins and profitability while expanding the business. A disciplined approach would be to quantify the implied revenue path and compare it to realistic milestones based on current growth rates and market dynamics.

FAQ

What is Nykaa's FY30 revenue growth target?

The Economic Times article reports Nykaa's FY30 roadmap targets up to 3x revenue growth.

Why did Nykaa's stock jump after the FY30 roadmap reveal?

Investors reacted to the ambitious growth targets, with Nykaa shares rising about 8% to a record high.

Does the article claim Nykaa will definitely achieve 3x revenue by FY30?

No. The article describes a target, not a guaranteed outcome, and actual results will depend on execution and market conditions.

What should retail investors monitor next regarding Nykaa's FY30 roadmap?

Investors should monitor quarterly results for progress toward milestones, margin improvements, and any updates on the roadmap from Nykaa's management.

Where can I read the original coverage of Nykaa's FY30 roadmap?

The original coverage is from the Economic Times; the article reports Nykaa's 8% stock jump to record high after unveiling the FY30 roadmap.

Conclusion

Nykaa's FY30 roadmap raises the growth bar for Indian consumer tech and e-commerce players, and the market has already rewarded the plan with an 8% stock move to a record high. For the retail investor, the immediate takeaway is to separate the headline excitement from execution risk: can Nykaa translate aspirational targets into real earnings growth? The answer depends on sustained top-line expansion, margin management, and the company’s ability to deliver milestones amid a competitive and evolving Indian e-commerce landscape.

Open your trading and demat account here

Key Takeaways

• Avience Biomedicals IPO on NSE SME is priced at ₹196-₹208 per share, with a total issue size up to ₹30 crore (fresh issue up to ₹29 crore) and 14,53,800 shares on offer; lot size is 600 shares.
• GMP data is not available yet; the most meaningful signal will come from subscription demand and eventual listing performance.
• Key risk: limited company background, SME-status, no confirmed lead manager, and no GMP signal as of now.
• Watchlist – wait for more data post-open (GMP, demand, and listing behavior) before committing capital.

Avience Biomedicals IPO details: price band, lot size, open/close dates, listing date

GMP signals and subscription trend for Avience Biomedicals IPO

As of now, GMP data for Avience Biomedicals IPO is not available, so there is no pre-listing price signal. The subscription trend will be the next big data point, given the small size of the offer and the NSE SME listing. Retail investors should monitor demand across quotas once the book is open and after it closes on 22 June.

Should you apply for Avience Biomedicals IPO at ₹196-₹208?

The price band sits at ₹196-₹208 with 600-share lots and a small ₹30 crore total size, which can be attractive only if the business is clearly visible and the demand supports it. In absence of strong business fundamentals and confirmed GMP, this issue may be suited to investors with high risk tolerance and small-ticket exposure. Evaluate your own risk profile and post-listing plan before applying.

Avience Biomedicals IPO valuation: is ₹196-₹208 justified?

There is no revenue or profit data in the available material, making it difficult to judge valuation against earnings, peers, or growth. The SME context, lack of GMP data, and the small issue size argue for caution. A clean, data-driven decision would require more information after listing or a robust pre-IPO financial track record.

Company background and risk factors for Avience Biomedicals IPO

The source identifies Avience Biomedicals as an SME-IPO issuing 14,53,800 equity shares of ₹10 face value aggregating up to ₹30 crore, with a fresh issue of ₹29 crore. No promoter names, product lines, or detailed business segments are provided in the material. This thin information base heightens execution risk for a small-cap IPO and warrants a cautious approach for retail investors with limited risk capital.

How to apply for Avience Biomedicals IPO: UPI/ASBA steps

Applications can be submitted via ASBA through your bank or via UPI-enabled IPO platforms. Steps include selecting the Avience Biomedicals IPO in your banking app or IPO app, choosing the bid quantity (a multiple of 600 shares), entering your bid price in a bookbuilding issue, and authorizing the bid by confirming your UPI ID. After you submit, funds stay in your account until successful allotment; unused funds are refunded after allotment. For retail investors, platforms like Swastika offer one-click IPO applications, but ensure you understand the risk and the time limits before applying.

Allotment and listing timeline for Avience Biomedicals IPO

The issue opens on 18 Jun 2026 and closes on 22 Jun 2026. Allotment dates and the official registrar details are yet to be announced. The listing is scheduled for 25 Jun 2026 on the NSE SME exchange. Investors should stay alert for the final allotment and listing confirmations from the registrar or exchange.

FAQ

Is Avience Biomedicals IPO worth applying for at ₹196-₹208?

As of now, GMP data is not available and the SME has limited business visibility; decide based on your risk tolerance and post-listing plan.

What is the GMP signal for Avience Biomedicals IPO?

GMP data is not available yet, so there is no pre-listing price signal at this time.

What are the allotment odds for Avience Biomedicals IPO?

Retail quota is 4,81,200 shares with a 600-share lot; allotment depends on demand across all quotas; specific odds are not disclosed.

When is the listing date for Avience Biomedicals IPO?

Listing on NSE SME is expected on 25 Jun 2026.

Who is the IPO registrar and lead manager?

Registrar is Skyline Financial Services Pvt. Ltd; Lead Manager is To be announced.

Conclusion

Avience Biomedicals is a small-ticket SME issue with limited business visibility and no GMP signal yet. Investors should watchlist this IPO for now, because GMP data is unavailable and the business narrative remains thin.

End of note: Watchlist because GMP is not available and data remains thin, so you should wait for more information before committing new capital.

Open your trading and demat account here

‍

Key Takeaways

• Clay Craft India Limited IPO details: price band ₹193-₹203, 54,24,000 shares on offer, up to ₹110 crore.
• GMP data not available yet, so listing demand signals remain unclear.
• Retail quota stands at 18,03,600 shares; no financial snapshot provided to gauge value.
• Action: weigh risk vs reward and decide to apply, watchlist, or wait for listing data.

Clay Craft India Limited IPO details at a glance

Clay Craft India Limited IPO: GMP, demand signals, and what it means for you

GMP data is not available yet; absence of GMP makes it hard to gauge short‑term listing gains. Subscription numbers and analyst consensus are not disclosed in the provided data; these signals typically guide risk assessment for small‑ticket SME issues.

Clay Craft India Limited IPO valuation: is the ₹193-₹203 band justified?

With an issue size of ₹110 crore and 54,24,000 shares on offer, the top of the band implies a rough take‑home valuation of ₹110 crore on listing; the majority of the issue is a fresh issue (~₹105 crore). However, there are no financial numbers in the source to anchor a P/E or margin valuation, so it remains a forward‑looking call rather than a discounted cash flow or earnings multiple play.

Should you apply: pros and cons for retail investors

Pros: Access to an SME listing with a relatively low price band and a sizable fresh capital component that could support growth. Cons: No revenue or profit figures in the material, no GMP signal, and the registrar/lead manager are yet to be announced, increasing execution risk. The lack of concrete financials makes valuation uncertain and raises the risk of mispricing on listing day.

Clay Craft India Limited IPO: How to apply via UPI/ASBA

SME IPO bids can be submitted via ASBA with funds blocked in your bank, or via UPI-based bidding on supported platforms. To apply via UPI, choose the UPI bid option during submission, enter quantity (minimum 600) and price within ₹193-₹203, then approve the payment. For convenience, retail investors can apply through platforms like Swastika before the issue closes on 19 Jun 2026.

Clay Craft India Limited IPO: Allotment and listing timeline

Allotment results are typically announced a few days after the closing date; closing is 19 June 2026 and listing is scheduled for 24 June 2026 on NSE SME. Investors should monitor the registrar and exchange portals for official allotment status and the final listing price.

FAQ

Is Clay Craft India Limited IPO worth applying for at ₹193-₹203?

The data shows a small-ticket SME IPO with no GMP or financials provided in the source, so the decision depends on your risk tolerance; a cautious approach would be to wait for more data or apply only if you can handle high risk.

What is GMP for Clay Craft India Limited IPO?

GMP data is not available yet, so there is no reliable signal on listing gains or demand at this time.

What are the allotment odds for Clay Craft India Limited IPO?

Allotment odds are not disclosed in the provided data; retail investors should expect the process to be demand-driven and monitor official announcements after closing on 19 June 2026.

When is the listing date for Clay Craft India Limited IPO?

The listing is expected on 24 June 2026 on the NSE SME platform.

What are the main risks of investing in this SME IPO?

Key risks include lack of disclosed financials (no revenue/profit figures in the data), no GMP data, and the general uncertainty around SME listings with limited visibility.

Conclusion

Clay Craft India Limited’s SME IPO presents a small-ticket growth bet with a large fresh‑capital component and limited data to anchor a valuation today. The absence of GMP data and visible financials means the risk is high and the price will largely reflect demand signals that are not yet disclosed. Watchlist this IPO if you have capital at risk and a high tolerance for SME execution risk; the decision to apply should come only after you see concrete GMP and financial visibility.

Open your trading and demat account here

‍

On June 16, 2026, millions of Indian traders woke up to a shocking surprise. Telegram was gone.

For them, this means no morning trade alerts, no buy-this-stock messages, no updates from the trading groups they had been following for months, sometimes years. Just silence.

The Indian government blocked Telegram across the entire country using Section 69A of the IT Act. The official reason was to stop fraud during the NEET-UG re-exam, where cheating rackets were reportedly selling fake question papers for ₹5,000 to ₹50,000. But the impact went far beyond students.

For India's massive retail trading community, this was not just a messaging blackout. It was a sudden cut-off from the app that millions had built their entire trading routine on.

India has over 15 crore unique registered investors today. A large portion of them were depending on Telegram groups every single day for trade tips, buy and sell signals, and market news. When the app went dark, so did their trading compass.

This blog is for every retail trader who felt that panic. We will tell you what happened, what the real risks were all along, and most importantly, what you should do right now.

Why Did Retail Traders Love Telegram So Much?

To understand why the ban hurt so many traders, you first need to understand why Telegram became so important to them in the first place.

It was not just a messaging app. For retail traders in India, Telegram was infrastructure. It was where trading happened before the market even opened.

Anyone could join a channel and start receiving buy and sell calls within seconds. No fees. No registration. No waiting. Telegram trading groups had up to 1 lakh members, and it genuinely felt like being inside a live trading room where hundreds of people were sharing real-time ideas together.

Breaking news, result announcements, F&O data, intraday ideas, everything came straight to your phone the moment it happened. And unlike Instagram or Twitter, Telegram showed every single message in order. Nothing was filtered or hidden by any algorithm.

Around 80% of young adults in India now receive financial advice through social media, and Telegram was the biggest hub for real-time trading signals. It felt like the smartest, fastest, most connected way to trade.

But there was a very dangerous side to all of this. And most traders chose not to look at it.

What the Telegram Ban Means for Traders

The ban has directly disrupted the daily trading life of crores of Indians. Here is what has changed overnight.

The buy and sell calls you depended on every morning are no longer arriving. For intraday traders especially, missing even one alert can mean a missed opportunity or an unexpected loss. The fast news updates and F&O data you were getting from channels are no longer accessible. The communities where you discussed ideas and learned from others are suddenly silent.

Trading is a routine-driven activity. When a core part of that routine disappears overnight, decision-making becomes harder and more stressful. Many traders are feeling genuinely lost right now.

But here is the question worth sitting with for a moment. Was depending on Telegram for all of this actually helping your trading? Or was it quietly working against you? The honest answer may surprise you.

The Risks of Telegram Trading That Nobody Talked About

Most traders never thought too deeply about where their tips were coming from. The signals felt real, the groups felt active, and occasionally a call would actually work out. That was enough to keep the habit going, but here is what was actually happening behind the scenes^.

^{You were Trusting Strangers With Your Money}

Most Telegram trading channels are run by completely anonymous people. You have no idea who they are, whether they have any real knowledge of markets, or whether they are even registered with SEBI as investment advisors. Every time you acted on one of those tips, you were trusting your hard-earned savings to someone you knew absolutely nothing about.

^{Nobody Was Accountable When Things Went Wrong}

When a tip goes wrong, and you lose money, what happens? The channel admin either disappears, blames the market, or simply moves on to the next call. There is no accountability. No refund. No explanation. You bear the entire loss alone.

You were not getting tips. You were being used as the exit for someone else's trade.

^{The 93% Loss Number That Every Trader Must Know}

SEBI conducted a landmark study on retail trader performance in India. The results were devastating. Between 91% and 93% of retail investors in the Futures and Options segment suffered losses in FY25. The total losses across these traders added up to ₹1.05 lakh crore. The average loss per trader was around ₹1.1 lakh.

The Telegram ban has removed something you depended on. But for many traders, it has also removed something that was quietly destroying their financial and mental wellbeing.

What Should An Investor Do Right Now?

First, do not panic because the ban is temporary. Use this week to make changes that will protect you long after Telegram comes back.

^{Stop Acting on Unverified Tips}

This is the single most important decision you can make. If you do not know who is giving you advice, what their track record is, and whether they are registered with SEBI, do not put your money on the line based on what they say. It really is that simple.

^{Look for SEBI-Registered Advisors and Platforms}

There are registered investment advisors and research analysts in India who are legally accountable for the recommendations they make. These are people who cannot simply disappear when a call goes wrong. Seek them out. Pay for proper advice if needed. It will cost far less than the losses from bad tips.

^{Start Building Your Own Understanding of Markets}

Even basic knowledge helps. Learning how to read a chart, understanding what support and resistance mean, or knowing how to look at a company's quarterly results can dramatically reduce your dependence on external signals. Use this quiet week to start.

^{Spread Your Information Sources}

Follow official BSE and NSE updates. Read credible financial news. Do not funnel everything through one app that can disappear overnight.

Meet Sarthi: The Trading Companion Built for You

At Swastika Investmart, we have been watching this problem grow for years. We understood the need traders have for timely, useful market ideas. And we built a proper solution.

Sarthi is a dedicated trade ideas feature inside the Swastika Investmart app, built specifically for Indian retail traders who want reliable, research-backed guidance without any of the risks that come with Telegram groups. Here is what Sarthi actually does for you every single day.

^{Complete Trade Ideas Across Equity, F&O, Intraday, and Commodity}

Whether you trade stocks, futures and options, or commodities, Sarthi covers it all. Every trade idea comes with a clear entry price, a target price, and a stop loss. You know exactly where to enter, what profit you are aiming for, and at what point to exit if the trade goes against you. No guesswork. No vague "buy this stock" messages. Just complete, actionable information every time.

^{Call Type Notifications So You Never Miss a Trade}

Sarthi sends you call type notifications directly through the Swastika app the moment a new trade idea is published. You do not need to keep checking a group chat or scrolling through hundreds of messages to find the one tip that matters. The alert comes to you, clearly labelled, ready to act on.

^{One Click Trade} 

This is where Sarthi truly stands apart. When you receive a trade call and want to act on it, you do not need to open a separate trading app, search for the stock, and manually fill in all the details. Simply tap Trade on the call. Sarthi takes you directly to the trading dashboard with everything already filled in, such as the stock, the entry price, the stop loss, and the target. All you need to do is enter the quantity and tap to place your order. That is it. From seeing the idea to placing the trade, the whole thing takes just a few seconds. In a market where timing matters, this is a genuine advantage.

^{A Full Track Record of Every Call Made}

This is something no Telegram group ever gave you. Sarthi shows you the complete performance history of every trade idea that has been published. You can see exactly how past calls performed, what the success rate looks like, and how the research team has done over time. Full transparency, nothing hidden. Before you follow any idea, you already know the track record behind it.

^{Built for Both Beginners and Experienced Traders}

Whether you have been trading for ten years or you are just starting, Sarthi is designed to make sense to you. The trade ideas are presented in simple, clear language. A beginner can understand what to do without needing to decode jargon. An experienced trader gets the depth and detail they need to make a confident decision. Everyone gets the same quality of research.

Telegram vs Sarthi: A Comparative View

Overall, we can say that one is a gamble dressed up as a trading community. The other is a system built on trust, research, and accountability.

Over to You: Invest Your Money Wisely

The Telegram ban will lift on June 22, 2026. The app will come back. The groups will reopen. The tips will start flowing again, but you do not have to go back to the way things were. 

SEBI's data tells us that 93 out of every 100 retail traders in the F&O segment lost money last year. That is not bad luck. That is a pattern. And a large part of that pattern is driven by the impulsive, herd-driven tip culture that Telegram made so easy to fall into.

This week of silence is a rare gift. A forced pause. A moment to honestly ask yourself: Am I trading with a proper system, or am I just following the crowd and hoping for the best?

The best traders are not the ones who get the most tips. They are the ones who get the right advice, from the right people, backed by real research. That is exactly what Sarthi is built to give you. Do not wait for the next ban to change how you trade. Make the shift today.

Disclaimer: This blog is for informational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please read all scheme-related documents carefully before investing.